COMMUNIQUÉS West-GlobeNewswire

Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn
23/12/2025
Seasoned executive brings four decades of finance, capital markets, and life sciences experience DURHAM, N.C., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical [...]
Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change
23/12/2025
RAMAT GAN, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and [...]
SeaStar Medical Announces 1-for-10 Reverse Split
23/12/2025
DENVER, Dec. 23, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and [...]
Organogenesis Announces Initiation of Biologics License Application for ReNu®
23/12/2025
Initial modules submitted to FDA under rolling review; final modules expected in the first half of 2026 CANTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative [...]
Algernon Announces Increase to Private Placement Financing to $750,000 and Close of Third Tranche
23/12/2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) ( [...]
Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors
23/12/2025
BOSTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Vor Biopharma Inc. (Nasdaq: VOR), a clinical-stage biotechnology company dedicated to transforming the treatment of autoimmune diseases, today announced the appointment [...]
Singlera Genomics Signs European Distribution and Research Agreement with Pure Medical for Cancer Detection Products
23/12/2025
LA JOLLA, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics, a company focused on the development and application of novel DNA methylation technologies to genetic diagnosis, today announced that it has entered [...]
Sequana Medical announces execution of letter of intent to amend terms of the Kreos Loan
23/12/2025
Ghent, Belgium, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Sequana Medical announces execution of letter of intent to amend terms of the Kreos Loan PRESS RELEASE REGULATED INFORMATION / INSIDE INFORMATION 23 December 2025, 6:30 [...]
West Hollywood Orthodontist Launches Free 'Student Airway Baseline' Screenings After Research Links Sleep-Disordered Breathing to Academic Struggles
23/12/2025
Harvard-trained orthodontist offers complimentary 15-minute airway analysis to help identify hidden causes of childhood focus problems LOS ANGELES, Dec. 23, 2025 (GLOBE NEWSWIRE) -- McComb Orthodontics , a specialty [...]
Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure
23/12/2025
CHARLOTTE, N.C., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company and parent of the IM8 premium health and longevity brand, today [...]
Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia
23/12/2025
Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address the underlying causes of ITP Approval based on [...]
Communiqué de presse : Wayrilz de Sanofi approuvé dans l’UE comme premier inhibiteur de la BTK pour le traitement de la thrombocytopénie immunitaire (TPI)
23/12/2025
Wayrilz de Sanofi approuvé dans l’UE comme premier inhibiteur de la BTK pour le traitement de la thrombocytopénie immunitaire (TPI) Un traitement novateur cible la BTK grâce à la modulation multi-immune pour aider à [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
23/12/2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 23 December 2025 at 16.00 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
J-Star’s LITZMO Introduces ER-01: The Brand’s First Carbon Fiber Fat-Tire E‑Assist Bicycle
23/12/2025
TAICHUNG CITY, Taiwan, Dec. 23, 2025 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions serving diverse [...]
Merit Medical to Participate at the J.P. Morgan Healthcare Conference
23/12/2025
SOUTH JORDAN, Utah, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management will participate in the 44th Annual J.P. Morgan [...]
Scilex Holding Company Confirms Dream Bowl 2026 Meme Coin Claim Process on December 24, 2025 Drop by Datavault AI Inc.
23/12/2025
PALO ALTO, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate
23/12/2025
SOLANA BEACH, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to [...]
Kailera Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
23/12/2025
WALTHAM, Mass. and SAN DIEGO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., an advanced clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced that Ron [...]
MAPS Supports Therapy Education for First-Ever Department of Defense-Affiliated MDMA-Assisted Therapy Pilot
23/12/2025
Training supports multi-site clinical trial of MDMA-assisted Massed Prolonged Exposure Therapy for PTSD in active-duty service members. First-of-its-kind therapist preparation supports the Department of Defense-funded [...]

Pages